US approves Johnson & Johnson's single-shot COVID-19 vaccine
The Food and Drug Administration on Saturday (February 27) as per local time cleared a Johnson & Johnson vaccine shot. Unlike most COVID-19 vaccines in use, it works with just one dose instead of two. During the trials, the J&J vaccine was found to be 85 per cent effective against the most severe COVID-19 illness.
0 Comments